The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The Zacks Rank is a proven strategy that targets ...

Given the surge in PRTH shares, we evaluate its current position to determine whether investors should jump on the stock's ...

Georgia has moved to renew contracts with Israeli technology firm Cellebrite DI Ltd for software used to extract data from ...

Meeting to be held in Chicago on March 5 and in Denver on March 6 hosted by Craig-Hallum. Discover the Best Stocks and Maximize Your Portfolio: ...

Meeting to be held in Toronto, Canada on March 4 hosted by Needham.Discover the Best Stocks and Maximize Your Portfolio: See what stocks are ...

Cellebrite DI Ltd. (NASDAQ:CLBT – Get Free Report) has received an average recommendation of “Buy” from the eight research ...

Cellebrite DI Ltd. (CLBT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in ...

Detailed price information for Cellebrite Di Ltd (CLBT-Q) from The Globe and Mail including charting and trades.

CLBT has been the subject of several other reports. Craig Hallum upped their price target on shares of Cellebrite DI from $23.00 to $24.00 and gave the company a “buy” rating in a research ...

It's been a mediocre week for Cellebrite DI Ltd. (NASDAQ:CLBT) shareholders, with the stock dropping 19% to US$20.50 in the week since its latest full-year results. The results overall were pretty ...

Cellebrite DI Ltd (CLBT) reports robust financial performance with a 25% increase in ARR and outlines future growth strategies amid ongoing CEO search.